To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Outcomes of the first global multidisciplinary consensus meeting including persons living with obesity to standardize patient-reported outcome measurement in obesity treatment research
Department of Surgery, OLVG, Amsterdam, The Netherlands.ORCID iD: 0000-0001-8885-9546
Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, TheNetherlands.
Department of Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands.
Department of Surgery, NMC Royal Hospital, Abu Dhabi, United Arab Emirates.
Show others and affiliations
2022 (English)In: Obesity Reviews, ISSN 1467-7881, E-ISSN 1467-789X, Vol. 23, no 8, article id e13452Article in journal (Refereed) Published
Abstract [en]

Quality of life is a key outcome that is not rigorously measured in obesity treatment research due to the lack of standardization of patient-reported outcomes (PROs) and PRO measures (PROMs). The S.Q.O.T. initiative was founded to Standardize Quality of life measurement in Obesity Treatment. A first face-to-face, international, multidisciplinary consensus meeting was conducted to identify the key PROs and preferred PROMs for obesity treatment research. It comprised of 35 people living with obesity (PLWO) and healthcare providers (HCPs). Formal presentations, nominal group techniques, and modified Delphi exercises were used to develop consensus-based recommendations. The following eight PROs were considered important: self-esteem, physical health/functioning, mental/psychological health, social health, eating, stigma, body image, and excess skin. Self-esteem was considered the most important PRO, particularly for PLWO, while physical health was perceived to be the most important among HCPs. For each PRO, one or more PROMs were selected, except for stigma. This consensus meeting was a first step toward standardizing PROs (what to measure) and PROMs (how to measure) in obesity treatment research. It provides an overview of the key PROs and a first selection of the PROMs that can be used to evaluate these PROs.

Place, publisher, year, edition, pages
John Wiley & Sons, 2022. Vol. 23, no 8, article id e13452
Keywords [en]
obesity treatment, patient-reported outcome measures, patient-reported outcomes, quality of life
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:oru:diva-99460DOI: 10.1111/obr.13452ISI: 000802005300001PubMedID: 35644939Scopus ID: 2-s2.0-85131003761OAI: oai:DiVA.org:oru-99460DiVA, id: diva2:1667235
Funder
Novo NordiskMedtronic, Sweden
Note

Funding agencies:

Johnson & Johnson USA  

Philips Vital Health 

Castor 

Bart Torensma 

Available from: 2022-06-10 Created: 2022-06-10 Last updated: 2022-08-22Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Ottosson, Johan

Search in DiVA

By author/editor
de Vries, Claire E. E.Ottosson, JohanHalford, Jason C. G.
By organisation
School of Medical SciencesÖrebro University Hospital
In the same journal
Obesity Reviews
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 67 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf